多癌种早期检测在头颈部鳞状细胞癌中的作用:病例系列
本文回顾性分析了2020年1月至2026年3月因Galleri MCED阳性提示HNSCC而转诊至耳鼻咽喉科的患者。共纳入3例,均为无症状且体格检查基本正常的早期p16+口咽鳞状细胞癌,均成功切除且早期随访无复发。提示MCED可能识别无症状早期HNSCC。
要点
- MCED阳性提示HNSCC的患者应系统评估,即使无症状且体检正常。
- 本文3例均为早期p16+口咽鳞癌,成功切除后早期随访无复发。
- 耳鼻咽喉科医生需准备系统评估MCED阳性转诊患者。
核心结论
- MCED检测可能识别无症状的早期头颈部鳞状细胞癌患者。
研究设计与样本
- 回顾性病例系列,纳入2020年1月至2026年3月因Galleri MCED阳性提示HNSCC转诊至耳鼻咽喉科的患者3例,回顾体格检查、软性喉镜、影像和治疗数据。
主要发现
- 3例患者均诊断为早期p16+口咽鳞状细胞癌,尽管无症状且体格检查基本无异常。
- 所有患者均成功切除,早期随访无复发证据。
临床怎么用
- 耳鼻咽喉科医生应对MCED阳性提示HNSCC的转诊患者进行系统评估,包括体格检查、软性喉镜和影像学检查。
局限性
- 本文为回顾性病例系列,样本量仅3例,随访时间短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) lacks an established screening program, and most cases are diagnosed at advanced stages. Multi-cancer early detection (MCED) blood-based assays represent a promising approach, yet real-world clinical experience with MCED-identified HNSCC remains limited. METHODS: We retrospectively reviewed patients referred to our Otolaryngology department with a positive Galleri MCED result indicating HNSCC between January 2020 and March 2026. Physical exam findings, flexible laryngoscopy findings, imaging, and treatment data for each patient was reviewed. RESULTS: Three patients were included in this case report. All three patients were diagnosed with early-stage p16+ oropharyngeal squamous cell carcinoma despite absent symptoms and largely unremarkable physical examinations. All underwent successful resection with no evidence of recurrent disease at early follow-up. CONCLUSIONS: MCED testing can potentially identify early-stage HNSCC in asymptomatic patients. Otolaryngologists should be prepared to systematically evaluate patients referred following a positive MCED result.
引用
- Talwar A, Ben-Levy O, Sriram N, et al. The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series. Head Neck. 2026. PMID: 42206762. doi:10.1002/hed.70337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。